New Non-Invasive Vaccine Strategy May Offer Protection Against Tetanus And Anthrax
Main Category: Immune System / VaccinesAlso Included In: Bio-terrorism / Terrorism
Article Date: 17 Jun 2006 - 3:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
5 (2 votes) |
A new vaccine strategy using genetically engineered bacteria topically applied to the skin elicits an immune response to both tetanus and anthrax in animals say researchers from Vaxin Inc., Birmingham, Alabama. They report their findings in the June 2006 issue of the journal Infection and Immunity.
The new vaccine strategy described in this study consists of a topically applied vaccine containing live Escherichia coli bacteria that are genetically engineered to produce proteins associated with the bacteria that cause anthrax and tetanus. These compounds can be administered by nonmedical personnel. Past studies have shown the outer layer of the skin to be more immunocompetent than deep tissue and experts believe that self-applied painless vaccines will further increase the compliance rate.
In the study mice were administered a topical E. coli vectored vaccine and then challenged with tetanus cells and anthrax spores. Ninety percent of the vaccinated mice infected with tetanus survived, those that didn't receive the vaccine died within five days. Of the mice vaccinated and challenged with anthrax, only 44% survived, but when additional E. coli particles were added, the survival rate increased to 55%.
"The nonreplicating E. coli vector overproducing an exogenous immunogen may foster the development of a new generation of vaccines that can be manufactured rapidly and administered noninvasively in a wide variety of disease settings," say the researchers.
###
J. Zhang, Z. Shi, F. Kong, E. Jex, Z. Huang, J.M. Watt, K.R. Van Kampen, D.C. Tang. 2006. Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity. Infection and Immunity, 74. 6: 3607-3617.
Contact: Carrie Patterson
American Society for Microbiology
Visit our immune system / vaccines section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/45272.php>
APA
http://www.medicalnewstoday.com/releases/45272.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



